Litcius/Paper detail

Negative <scp>DAT‐SPECT</scp> in Old Onset Parkinson's Disease: An Additional Pitfall?

Giovanni Palermo, S Giannoni, Tommaso Depalo, Daniela Frosini, Duccio Volterrani, Gabriele Siciliano, Ubaldo Bonuccelli, Roberto Ceravolo

2022Movement Disorders Clinical Practice10 citationsDOIOpen Access PDF

Abstract

Background: Scans without evidence of dopaminergic deficit (SWEDDs) refer to patients clinically diagnosed with Parkinson's disease (PD), but showing normal findings on dopamine transporter single-photon emission computed tomography (DAT-SPECT). This entity remains highly debated, but recent findings suggesting that DAT-SPECT does not reflect either nigral cell bodies or striatal fibers of dopaminergic nigrostriatal neurons could improve our understanding of SWEDDs. Notably, compensatory downregulation of DAT in the early stages of PD seems to be less efficient in older-onset than in young-onset patients. Cases: We report eight patients with old-onset clinical parkinsonism and a positive response to levodopa in which DAT-SPECT was normal both visually and semiquantitatively. Two subjects demonstrated an abnormal scan when repeated later. Conclusions: We suggest that old-onset patients may truly have dopaminergic degeneration despite normal imaging results, presumably because they are diagnosed in the early stages confirming less efficient striatal compensatory strategies in old-age onset PD.

Topics & Concepts

Dopamine transporterDopaminergicParkinsonismParkinson's diseaseSingle-photon emission computed tomographySpect imagingLevodopaNeuroscienceMedicineDiseasePsychologyDopamineInternal medicinePathologyNuclear medicineParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNeurotransmitter Receptor Influence on Behavior